Continuous ambulatory peritoneal dialysis (CAPD) in the treatment of end-stage renal failure.
Our experience of CAPD in 21 patients over a total period of 118 patients months has been evaluated and compared with intermittent peritoneal dialysis (IPD). CAPD was associated with greater clearance of urea creatinine and phosphate, higher concentrations of haemoglobin, improved control of hypertension and saline overload, and better patient acceptance than IPD. It is concluded that CAPD is an effective form of dialysis with many advantages over IPD, although the incidence of peritonitis is still twice that IPD.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D001806:Blood Urea Nitrogen; D002118:Calcium / Q000097:blood; D055598:Chemical Phenomena; D002621:Chemistry; D002648:Child; D003404:Creatinine / Q000097:blood; D005260:Female; D006454:Hemoglobins; D006801:Humans; D006973:Hypertension / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis / Q000009:adverse effects; D010538:Peritonitis / Q000209:etiology; D012965:Sodium Chloride / Q000494:pharmacology; D013997:Time Factors
D006454:Hemoglobins; D012965:Sodium Chloride; D003404:Creatinine; D002118:Calcium